PROVIDER PROFILE · NPI 1528153467

Bienvenido FajardoM.D.

PRACTICEBIENVENIDO FAJARDO, M.D.P.C.See all providers at this practice →

Internal MedicineNew York, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

522

Unique beneficiaries

—

Total services

705

Distinct HCPCS

Medicare payment

$24K

Peer benchmark

Total Medicare services vs. 7,864 Internal Medicine providers in NY — above median (cohort median 552).

PRESCRIBING · PART D · 2024

Total Rx claims

12,475

Beneficiaries

—

Total drug cost

$1.7M

Distinct drugs

142

Brand share

29.1%

Top prescribed drugs

Atorvastatin Calcium945 claims

Amlodipine Besylate538 claims

Omeprazole491 claims

Metformin Hcl484 claims

Gabapentin415 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$285

Payment records

By payment type

Food and Beverage$285

REFERRAL NETWORK

Where Bienvenido Fajardo's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Empire City Laboratories, Inc Clinical Laboratory · Brooklyn, NY	137	1,030
THE NEW YORK AND PRESBYTERIAN HOSPITAL	40	131
Claudia Serrano-Gomez Cardiology · New York, NY	21	41
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	18	48
Casilda Balmaceda Neurology · New York, NY	15	34

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history